Biosimilars : design and analysis of follow-on biologics / / Shein-Chung Chow.
"Biologic drug products are therapeutic moieties that are manufactured using a living system or organism. These are important life-saving drug products for patients with unmet medical needs. They also comprise a growing segment in the pharmaceutical industry. In 2007, for instance, worldwide sa...
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Year of Publication: | 2014 |
Language: | English |
Series: | Chapman & Hall/CRC biostatistics series ;
60 |
Online Access: | |
Physical Description: | xix, 410 p. :; ill. |
Notes: | "A Chapman & Hall book." |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
5001316405 |
---|---|
ctrlnum |
(MiAaPQ)5001316405 (Au-PeEL)EBL1316405 (CaPaEBR)ebr10733726 (CaONFJC)MIL518837 (OCoLC)854975436 |
collection |
bib_alma |
record_format |
marc |
spelling |
Chow, Shein-Chung, 1955- Biosimilars [electronic resource] : design and analysis of follow-on biologics / Shein-Chung Chow. Boca Raton : Taylor & Francis, 2014. xix, 410 p. : ill. Chapman & Hall/CRC biostatistics series ; 60 "A Chapman & Hall book." Includes bibliographical references. "Biologic drug products are therapeutic moieties that are manufactured using a living system or organism. These are important life-saving drug products for patients with unmet medical needs. They also comprise a growing segment in the pharmaceutical industry. In 2007, for instance, worldwide sales of biological products reached $94 billion US dollars, accounting for about 15% of the pharmaceutical industry's gross revenue. Meanwhile, many biological products face losing their patents in the next decade"-- Provided by publisher. Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. Pharmaceutical biotechnology. Pharmaceutical biotechnology industry. Drugs Generic substitution. Pharmaceutical policy. Biological products. Electronic books. ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1316405 Click to View |
language |
English |
format |
Electronic eBook |
author |
Chow, Shein-Chung, 1955- |
spellingShingle |
Chow, Shein-Chung, 1955- Biosimilars design and analysis of follow-on biologics / Chapman & Hall/CRC biostatistics series ; |
author_facet |
Chow, Shein-Chung, 1955- ProQuest (Firm) ProQuest (Firm) |
author_variant |
s c c scc |
author2 |
ProQuest (Firm) |
author2_role |
TeilnehmendeR |
author_corporate |
ProQuest (Firm) |
author_sort |
Chow, Shein-Chung, 1955- |
title |
Biosimilars design and analysis of follow-on biologics / |
title_sub |
design and analysis of follow-on biologics / |
title_full |
Biosimilars [electronic resource] : design and analysis of follow-on biologics / Shein-Chung Chow. |
title_fullStr |
Biosimilars [electronic resource] : design and analysis of follow-on biologics / Shein-Chung Chow. |
title_full_unstemmed |
Biosimilars [electronic resource] : design and analysis of follow-on biologics / Shein-Chung Chow. |
title_auth |
Biosimilars design and analysis of follow-on biologics / |
title_new |
Biosimilars |
title_sort |
biosimilars design and analysis of follow-on biologics / |
series |
Chapman & Hall/CRC biostatistics series ; |
series2 |
Chapman & Hall/CRC biostatistics series ; |
publisher |
Taylor & Francis, |
publishDate |
2014 |
physical |
xix, 410 p. : ill. |
callnumber-first |
R - Medicine |
callnumber-subject |
RS - Pharmacy |
callnumber-label |
RS380 |
callnumber-sort |
RS 3380 C45 42014 |
genre |
Electronic books. |
genre_facet |
Electronic books. |
url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1316405 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
615 - Pharmacology & therapeutics |
dewey-full |
615.1/9 |
dewey-sort |
3615.1 19 |
dewey-raw |
615.1/9 |
dewey-search |
615.1/9 |
oclc_num |
854975436 |
work_keys_str_mv |
AT chowsheinchung biosimilarsdesignandanalysisoffollowonbiologics AT proquestfirm biosimilarsdesignandanalysisoffollowonbiologics |
status_str |
n |
ids_txt_mv |
(MiAaPQ)5001316405 (Au-PeEL)EBL1316405 (CaPaEBR)ebr10733726 (CaONFJC)MIL518837 (OCoLC)854975436 |
is_hierarchy_title |
Biosimilars design and analysis of follow-on biologics / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1792330753809317888 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02102nam a2200433 a 4500</leader><controlfield tag="001">5001316405</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">130405s2014 fluad sb 000 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2013012926</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781466579699 (hardback)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781466579705 (e-book)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5001316405</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL1316405</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10733726</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL518837</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)854975436</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS380</subfield><subfield code="b">.C45 2014</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615.1/9</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chow, Shein-Chung,</subfield><subfield code="d">1955-</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biosimilars</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">design and analysis of follow-on biologics /</subfield><subfield code="c">Shein-Chung Chow.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Boca Raton :</subfield><subfield code="b">Taylor & Francis,</subfield><subfield code="c">2014.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xix, 410 p. :</subfield><subfield code="b">ill.</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Chapman & Hall/CRC biostatistics series ;</subfield><subfield code="v">60</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"A Chapman & Hall book."</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"Biologic drug products are therapeutic moieties that are manufactured using a living system or organism. These are important life-saving drug products for patients with unmet medical needs. They also comprise a growing segment in the pharmaceutical industry. In 2007, for instance, worldwide sales of biological products reached $94 billion US dollars, accounting for about 15% of the pharmaceutical industry's gross revenue. Meanwhile, many biological products face losing their patents in the next decade"--</subfield><subfield code="c">Provided by publisher.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical biotechnology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical biotechnology industry.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Generic substitution.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical policy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biological products.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1316405</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |